|
H2AFY expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.079500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.707000E-01 |
| Normal-vs-Stage2 |
2.557800E-01 |
| Normal-vs-Stage3 |
6.447800E-02 |
| Normal-vs-Stage4 |
2.917900E-03 |
| Stage1-vs-Stage2 |
6.347400E-01 |
| Stage1-vs-Stage3 |
2.475000E-01 |
| Stage1-vs-Stage4 |
6.544000E-03 |
| Stage2-vs-Stage3 |
7.438400E-01 |
| Stage2-vs-Stage4 |
1.585230E-01 |
| Stage3-vs-Stage4 |
1.749190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.160190E-01 |
| Normal-vs-AfricanAmerican |
7.213800E-02 |
| Normal-vs-Asian |
1.530980E-01 |
| Caucasian-vs-AfricanAmerican |
5.571600E-01 |
| Caucasian-vs-Asian |
2.418800E-01 |
| AfricanAmerican-vs-Asian |
3.018600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.912300E-02 |
| Normal-vs-Female |
1.194150E-01 |
| Male-vs-Female |
6.855400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.187600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.550000E-02 |
| Normal-vs-Age(61-80Yrs) |
9.244400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.828800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.686000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.205000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.125600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.400800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.103800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.308000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.428000E-01 |
| Normal-vs-Grade 2 |
4.341400E-01 |
| Normal-vs-Grade 3 |
5.539800E-02 |
| Normal-vs-Grade 4 |
2.193300E-04 |
| Grade 1-vs-Grade 2 |
4.010200E-01 |
| Grade 1-vs-Grade 3 |
1.816440E-01 |
| Grade 1-vs-Grade 4 |
2.176700E-03 |
| Grade 2-vs-Grade 3 |
7.538100E-02 |
| Grade 2-vs-Grade 4 |
3.837500E-04 |
| Grade 3-vs-Grade 4 |
1.195760E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.640000E-01 |
| Normal-vs-ccB subtype |
1.045780E-04 |
| ccA subtype-vs-ccB subtype |
2.34529995424282E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.473700E-02 |
| Normal-vs-N1 |
2.04899999999286E-05 |
| N0-vs-N1 |
7.644500E-04 |
|
|
